Skip to content

The Effect of Vitamin D supplementation on the lipid profile of women with PCOS attending the gynaecological OPD in a tertiary care teaching hospital- a Randomised Placebo controlled trial

The Effect of Vitamin D supplementation on the lipid profile of women with PCOS attending the gynaecological OPD in a tertiary care teaching hospital- a Randomised Placebo controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075349
Enrollment
142
Registered
2024-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: VITAMIN D capsule 60,000 IU: to be given once weekly for 8 weeks Control Intervention1: anti acidity tablets: similar softgel capsules

Sponsors

various pharmacological drug companies free samples
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: women with pcos

Exclusion criteria

Exclusion criteria: Women with normal vitamin d levels ? Hypothyroidism ? Familial hypercholesterelemia ? Secondary hypercholesterelemia ? Women with PCOS not receiving any drug therapy (not on OCPs) ? Women with PCOS receiving any other drug besides low dose OCPs for treatment of PCOS ie anti testosterone drugs/ GnRH analogues. ? Women taking any other drugs that may lower the serum LDL levels ie Statins, etc.

Design outcomes

Primary

MeasureTime frame
expected reduction in serum ldl levelsTimepoint: expected reduction in serum ldl levels

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactMonica Shah

IPGMER and SSKM hospital

monicashah123.ms@gmail.com9831142720

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026